Evolve Biosystems is an infant nutrition that develops microbial products that are key to the development of gut & immune health.
Location: United States, California, Davis
Employees: 11-50
Total raised: $69M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | iSelect Fu... | iselectfun... |
| - | Spruce Cap... | sprucecp.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 13.06.2018 | Series C | $40M | - |
| 30.05.2017 | Series B | $20M | - |
| 17.08.2015 | Series A | $9M | - |
Mentions in press and media 19
| Date | Title | Description |
| 11.03.2021 | Evolve BioSystems, Inc. Announces the Use of Activated B. infantis EVC001 by International Consortium to Study the Prevention of Type 1 Diabetes in Children | |
| 10.02.2021 | Evolve BioSystems gets $55 million investment led by Cargill | Evolve Biosystems is an independent microbiome research company that was launched out of University of California, Davis in 2014. It was initially funded by the Bill & Melinda Gates Foundation. Also participating in the funding announce... |
| 09.02.2021 | Evolve BioSystems Announces $55M in Series D | DAVIS, CA, Evolve BioSystems announced it completed a first close in a $55M Series D round of funding, led by Cargill and Manna Tree. >> Click here for more funding data on Evolve BioSystems >> To export Evolve BioSystems fu... |
| 08.02.2021 | Daily funding roundup - February 8th, 2021 | Evolve BioSystems raised $55M; Getaway landed $41.7M; BeyondID secured $9M; Lyte picks up $5M Evolve BioSystems: Evolve BioSystems is Davis, Ca-based probiotic tech startup aiming to improve ifant gut health. Evolve BioSystems has raised fu... |
| 29.01.2020 | EXCLUSIVE: Acre VP holds first close of Fund II, brings on Greylock’s Bill Helman as partner & LP | Acre Venture Partners (Acre VP), the agri-foodtech investment firm, has reached a first close on its second fund, a multi-LP fund targeting around $125 million, the same size it reached for Fund I. The firm was founded in 2016 when it launc... |
| 14.06.2018 | Evolve Biosystems Nabs $40M Series C | DAVIS, CA, Evolve BioSystems, the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding. >> Click here for more funding data on Evolve Biosystems >> To export Ev... |
| 14.06.2018 | Term Sheet — Thursday, June 14 | 5 Qs WITH A DEALMAKER You probably haven’t heard of Fleetcor Technologies. Paid Content How can you protect what you can't see? From ExtraHop But what is quite interesting is Fleetcor’s acquisition strategy. Since the company’s inception in... |
| 13.06.2018 | Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo | DAVIS, Calif., June 13, 2018 /PRNewswire/ -- Evolve BioSystems, Inc., the leading infant gut microbiome company, today announced that it has completed a $40 million Series C round of funding co-led by the Bill & Melinda Gates Foundation... |
| 13.06.2018 | Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo | - |
| 13.06.2018 | Evolve BioSystems Raises $40M in Series C Financing | Evolve BioSystems, Inc., a Davis, CA-based infant gut microbiome company, completed $40m Series C round of funding. The round was co-led by the Bill & Melinda Gates Foundation, and Horizons Ventures, the venture division of the Li Ka Sh... |
Show more